ALLO · Allogene Therapeutics, Inc.

$2.05 +0.07 (+3.54%) At close · Aug 14

Market Cap

$708.26M

345.49M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David Chang	M.D., Ph.D. President and Chief Executive Officer	$724,000	—	$1,016,960	$2,401,683	$329,420	$10,145	$4,482,208
Zachary J. Roberts M.D	Chief Medical Officer and Executive Vice President of Research and Development	$530,207	—	$448,000	$1,058,010	$167,015	$17,525	$2,220,757
Timothy Moore	Former Executive Vice President and Chief Technology Officer	$525,000	—	$309,120	$730,027	$165,375	—	$1,729,522

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David Chang	M.D., Ph.D. President and Chief Executive Officer	$724,000	—	$7,996,888	$5,070,365	$270,595	$2,000	$14,063,848
Zachary J. Roberts M.D	Chief Medical Officer and Executive Vice President of Research and Development	$522,813	$75,000	$3,533,710	$3,850,445	$134,727	$16,850	$8,133,545
Timothy Moore	Former Executive Vice President and Chief Technology Officer	$360,938	$100,000	$2,249,987	$2,999,886	$93,416	—	$5,804,227

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David Chang	M.D., Ph.D. President and Chief Executive Officer	$724,000	—	—	$13,697,357	$376,480	—	$14,797,837
Eric Schmidt	Chief Financial Officer	$490,000	—	$2,299,999	$2,299,553	$176,400	$13,725	$5,279,677
Alison Moore	Chief Technical Officer	$490,000	—	$0	$4,599,111	$176,400	$13,725	$5,279,236
Rafael Amado	Former Executive Vice President of Research and Development	$633,627	—	$2,299,999	$2,299,553	—	$11,531	$5,244,710
Veer Bhavnagri	—	$480,000	—	$1,699,994	$1,699,667	$172,800	$13,725	$4,066,186

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David Chang	M.D., Ph.D. President and Chief Executive Officer	$695,000	—	$2,717,669	$6,352,635	$396,150	—	$10,161,454
Rafael Amado	Former Executive Vice President of Research and Development	$571,591	$100,000	$6,839,951	$1,963,489	$228,000	$11,125	$9,714,156
Alison Moore	Chief Technical Officer	$475,000	$75,000	$839,973	$1,963,489	$180,500	$13,050	$3,547,012
Eric Schmidt	Chief Financial Officer	$475,000	—	$839,973	$1,963,489	$180,500	—	$3,458,962
Former General Counsel	—	$464,000	—	$749,984	$1,753,120	$176,320	$13,050	$3,156,474

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David Chang	M.D., Ph.D. President and Chief Executive Officer	$675,000	—	—	$6,550,535	$506,250	$83,256	$7,815,041
Rafael Amado	Former Executive Vice President of Research and Development	$510,000	$75,000	$561,176	$1,262,643	$255,000	—	$2,663,819
Eric Schmidt	Chief Financial Officer	$440,000	—	$561,176	$1,262,643	$220,000	—	$2,483,819
Alison Moore	Chief Technical Officer	$440,000	—	$561,176	$1,262,643	$220,000	—	$2,483,819
Former General Counsel	—	$425,000	—	$537,490	$1,211,953	$212,500	$9,385	$2,396,328
Veer Bhavnagri	—	$425,000	—	$537,490	$1,211,953	$212,500	$9,385	$2,396,328
General Counsel	—	$425,000	—	$537,490	$1,211,953	$212,500	$9,385	$2,396,328

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David Chang	M.D., Ph.D. President and Chief Executive Officer	$600,000	—	$4,651,970	$5,327,140	$363,000	$250,000	$11,192,110
Rafael Amado	Chief Medical Officer and Executive Vice President of Research and Development	$145,833	—	$4,249,976	$2,759,623	$71,726	$225,000	$7,452,158
Eric Schmidt	Chief Financial Officer	$425,000	—	$1,328,366	$1,519,700	$187,000	—	$3,460,066
Alison Moore	Chief Technical Officer	$425,000	—	$996,275	$1,519,700	$187,000	—	$3,127,975

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David Chang	M.D., Ph.D. President and Chief Executive Officer	$362,413	—	$8,948,152	$3,070,331	$217,641	$250,000	$12,848,537
Eric Schmidt	Chief Financial Officer	$201,232	—	—	$2,299,658	$88,099	—	$2,588,989
Alison Moore	Chief Technical Officer	$233,265	—	—	$1,401,225	$102,124	$100,000	$1,836,614

Executive changes

Person	Role	Change	Effective	Filed
Zachary Roberts, M.D., Ph.D.	Class I director	Appointed	2026-07-01	2026-05-28
Zachary Roberts, M.D., Ph.D.	President and Chief Executive Officer	Appointed	2026-07-01	2026-05-28
Timothy Moore	employment with the Company	Terminated	2025-02-28	2025-01-29
Annie Yoshiyama	principal accounting officer	Appointed	2024-06-05	2024-06-10
Geoffrey Parker	Executive Vice President, Chief Financial Officer, Principal Financial Officer, and Principal Accounting Officer	Appointed	2023-10-16	2023-10-16
Eric Schmidt, Ph.D.	Chief Financial Officer, principal financial officer and principal accounting officer	Resigned	2023-08-02	2023-06-14
Tim Moore	Chief Technical Officer	Appointed	2023-04-24	2023-04-20
Alison Moore	Chief Technical Officer	Resigned	2023-04-28	2023-04-20
Rafael G. Amado, M.D.	Executive Vice President of Research and Development	Resigned	2022-12-30	2023-01-03
Stephen Mayo, Ph.D.	Class III director	Appointed	2022-07-08	2022-07-12

Key facts CIK 1737287 CUSIP 019770106 13F (30d) 203 filings 200 filers Visit website Investor relations